Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00621374 · ClinicalTrials.gov registry record · NA

Management of Pain in Persons With Multiple Sclerosis

A NA study of Pain and Multiple Sclerosis, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT00621374 is a NA study of Pain and Multiple Sclerosis that has completed, run by University of Washington. The registered enrollment target is 22 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00621374, a NA study of Pain and Multiple Sclerosis, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if treatments that include components of self-hypnosis training and cognitive behavioral therapy (CBT) can help decrease pain in people with MS.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Cognitive Behavioral Therapy (CBT) +Hypnosis (HYP)
  • BEHAVIORAL Self-Hypnosis Training (HYP)
  • BEHAVIORAL Education Control (CONT)

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2008-02
Est. Completion 2009-06
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT00621374

The ClinicalTrials.gov registry entry for NCT00621374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT00621374 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00621374 about?

NCT00621374 is a clinical study titled "Management of Pain in Persons With Multiple Sclerosis". The purpose of this study is to see if treatments that include components of self-hypnosis training and cognitive behavioral therapy (CBT) can help decrease pain in people with MS.

What is the current status of trial NCT00621374?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2008-02. Estimated completion is 2009-06.

What conditions does trial NCT00621374 study?

This clinical trial studies the following conditions: Pain, Multiple Sclerosis.

What interventions are being tested in trial NCT00621374?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Cognitive Behavioral Therapy (CBT) +Hypnosis (HYP) (BEHAVIORAL), Self-Hypnosis Training (HYP) (BEHAVIORAL), Education Control (CONT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00621374?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00621374 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.